guaifenesin has been researched along with Cacosmia in 15 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Daily cough was recorded in 28." | 1.48 | Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations. ( Crespo, A; García-Rivero, JL; López-Viña, A; Marina-Malanda, N; Martínez-Rivera, C; Mayoralas-Alises, S; Padilla, A; Pallarés-Sanmartín, A; Pascual-Erquicia, S; Picado, C; Pinedo-Sierra, C; Plaza, V, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ijichi, C | 1 |
| Wakabayashi, H | 1 |
| Sugiyama, S | 1 |
| Hayashi, K | 1 |
| Ihara, Y | 1 |
| Nishijima, H | 1 |
| Touhara, K | 1 |
| Kondo, K | 1 |
| Liu, Z | 2 |
| Hong, J | 2 |
| Huang, X | 2 |
| Wu, D | 2 |
| Bleier, BS | 1 |
| Yoo, F | 1 |
| Soler, ZM | 3 |
| Mulligan, JK | 2 |
| Storck, KA | 1 |
| Lamira, JM | 1 |
| Pasquini, WN | 1 |
| Hill, JB | 1 |
| Noonan, TE | 1 |
| Washington, BJ | 1 |
| Schlosser, RJ | 2 |
| Khashkhosha, HK | 1 |
| Elhadi, M | 1 |
| Bodner, TE | 1 |
| Alt, JA | 2 |
| Ramakrishnan, VR | 1 |
| Mattos, JL | 1 |
| Mace, JC | 2 |
| Smith, TL | 2 |
| Martínez-Rivera, C | 1 |
| Crespo, A | 1 |
| Pinedo-Sierra, C | 1 |
| García-Rivero, JL | 1 |
| Pallarés-Sanmartín, A | 1 |
| Marina-Malanda, N | 1 |
| Pascual-Erquicia, S | 1 |
| Padilla, A | 1 |
| Mayoralas-Alises, S | 1 |
| Plaza, V | 1 |
| López-Viña, A | 1 |
| Picado, C | 1 |
| Wu, J | 1 |
| Chandra, RK | 1 |
| Li, P | 1 |
| Hull, BP | 1 |
| Turner, JH | 1 |
| Henkin, RI | 4 |
| Schmidt, L | 2 |
| Velicu, I | 4 |
| DeConde, AS | 1 |
| Orlandi, RR | 1 |
| Cooperstein, E | 1 |
| Gilbert, J | 1 |
| Epstein, JB | 1 |
| Dietrich, MS | 1 |
| Bond, SM | 1 |
| Ridner, SH | 1 |
| Wells, N | 1 |
| Cmelak, A | 1 |
| Murphy, BA | 1 |
| Suzuki, M | 1 |
| Saito, K | 1 |
| Min, WP | 1 |
| Vladau, C | 1 |
| Toida, K | 1 |
| Itoh, H | 1 |
| Murakami, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Determinants of Olfactory Dysfunction in Chronic Rhinosinusitis[NCT02720653] | 418 participants (Actual) | Observational | 2016-07-01 | Active, not recruiting | |||
| "Validation of a Questionnaire to Assess Bronchial Mucus Hypersecretion in Asthmatic Patients. Questionnaire T-sec (Secretion Test)."[NCT05546645] | 100 participants (Anticipated) | Observational | 2023-10-01 | Recruiting | |||
| Determinants of Medical and Surgical Treatment Outcomes in Chronic Sinusitis[NCT01332136] | 966 participants (Actual) | Observational | 2011-04-30 | Completed | |||
| A Randomized, Double-Blinded, Placebo-Controlled Trial to Determine The Safety and Efficacy of CYR-064[NCT06019000] | Phase 2 | 150 participants (Anticipated) | Interventional | 2023-09-26 | Recruiting | ||
| Efficacy of Bimodal Visual-Olfactory Training in Participants With COVID-19 Resultant Hyposmia or Anosmia Using Participant-Preferred Scents[NCT04710394] | 240 participants (Actual) | Interventional | 2021-01-11 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for guaifenesin and Cacosmia
| Article | Year |
|---|---|
A hypothesis on the role of the human immune system in covid-19.
Topics: Ageusia; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-1 | 2020 |
1 trial available for guaifenesin and Cacosmia
| Article | Year |
|---|---|
Investigation of change in cardinal symptoms of chronic rhinosinusitis after surgical or ongoing medical management.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Canada; Chronic Disease; Cohort Studies; Endo | 2015 |
13 other studies available for guaifenesin and Cacosmia
| Article | Year |
|---|---|
Odorant metabolism of the olfactory cleft mucus in idiopathic olfactory impairment patients and healthy volunteers.
Topics: Healthy Volunteers; Hexanols; Humans; Middle Aged; Mucus; Odorants; Olfaction Disorders; Smell | 2022 |
Olfactory cleft mucus galectin-10 predicts olfactory loss in chronic rhinosinusitis.
Topics: Chronic Disease; Galectins; Humans; Mucus; Nasal Polyps; Olfaction Disorders; Rhinitis; Sinusitis; S | 2023 |
Olfactory cleft mucus eosinophil-derived neurotoxin better reflects olfactory loss than blood eosinophil counts in patients with chronic rhinosinusitis.
Topics: Anosmia; Chronic Disease; Eosinophil-Derived Neurotoxin; Eosinophils; Humans; Mucus; Olfaction Disor | 2023 |
Olfactory cleft mucus proteins associated with olfactory dysfunction in a cohort without chronic rhinosinusitis.
Topics: Adult; Aged; Chronic Disease; Cohort Studies; Cyclin-Dependent Kinase Inhibitor p16; Diagnosis, Diff | 2019 |
Endotyping chronic rhinosinusitis based on olfactory cleft mucus biomarkers.
Topics: Adult; Aged; Biomarkers; Chronic Disease; Cluster Analysis; Cytokines; Female; Humans; Male; Middle | 2021 |
Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.
Topics: Adult; Aged; Asthma; Cough; Disease Progression; Female; Humans; Male; Middle Aged; Mucus; Olfaction | 2018 |
Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis.
Topics: Adult; Case-Control Studies; Chronic Disease; Cytokines; Female; Humans; Male; Middle Aged; Mucus; O | 2018 |
Interleukin 6 in hyposmia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Child; Female; Humans; Interleukin | 2013 |
Differences between and within human parotid saliva and nasal mucus cAMP and cGMP in normal subjects and in patients with taste and smell dysfunction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Cyclic AMP; Cyclic GMP; Fem | 2011 |
Relative resistance to oral theophylline treatment in patients with hyposmia manifested by decreased secretion of nasal mucus cyclic nucleotides.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cyclic AMP; Cyclic GMP; Female; Humans; Male; | 2011 |
Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health.
Topics: Appetite; Chemoradiotherapy; Cohort Studies; Cross-Sectional Studies; Deglutition Disorders; Dentin | 2012 |
Aetiological relationships of nasal mucus cyclic nucleotides in patients with taste and smell dysfunction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cyclic AMP; Cyclic GMP; Female; Humans; Male; Mid | 2012 |
Identification of viruses in patients with postviral olfactory dysfunction.
Topics: Adolescent; Adult; Aged; Child; Coronavirus; Female; Follow-Up Studies; Herpesvirus 4, Human; Humans | 2007 |